These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 28891831)

  • 41. Mucosal features and granulocyte-monocyte-apheresis in steroid-dependent/refractory ulcerative colitis.
    D'Ovidio V; Aratari A; Viscido A; Marcheggiano A; Papi C; Capurso L; Caprilli R
    Dig Liver Dis; 2006 Jun; 38(6):389-94. PubMed ID: 16569521
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Efficacy and safety of granulocyte, monocyte/macrophage adsorptive in pediatric ulcerative colitis.
    Ruuska T; Küster P; Grahnquist L; Lindgren F; Wewer AV
    World J Gastroenterol; 2016 May; 22(17):4389-96. PubMed ID: 27158208
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mucosal cytokine production in radiation-induced proctosigmoiditis compared with inflammatory bowel disease.
    Indaram AV; Visvalingam V; Locke M; Bank S
    Am J Gastroenterol; 2000 May; 95(5):1221-5. PubMed ID: 10811331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Dietary polysaccharide-rich extract from Eucheuma cottonii modulates the inflammatory response and suppresses colonic injury on dextran sulfate sodium-induced colitis in mice.
    Sudirman S; Hsu YH; He JL; Kong ZL
    PLoS One; 2018; 13(10):e0205252. PubMed ID: 30289911
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intestinal expression of the anti-inflammatory interleukin-1 homologue IL-37 in pediatric inflammatory bowel disease.
    Weidlich S; Bulau AM; Schwerd T; Althans J; Kappler R; Koletzko S; Mayr D; Bufler P
    J Pediatr Gastroenterol Nutr; 2014 Aug; 59(2):e18-26. PubMed ID: 24732025
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Granulomonocytapheresis as a cell-dependent treatment option for patients with inflammatory bowel disease: Concepts and clinical features for better therapeutic outcomes.
    Saniabadi AR; Tanaka T; Yamamoto T; Kruis W; Sacco R
    J Clin Apher; 2019 Feb; 34(1):51-60. PubMed ID: 30407662
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Efficacy and Usefulness of New Single-Needle Intensive Granulocyte and Monocyte Adsorptive Apheresis in Active Ulcerative Colitis Patients Without Corticosteroids and Biologics.
    Shimazu K; Fukuchi T; Kim I; Noguchi Y; Iwata M; Koyama S; Ubukata S; Tanaka A
    Ther Apher Dial; 2016 Aug; 20(4):383-9. PubMed ID: 27523079
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Opposite effects of interferon regulatory factor 1 and osteopontin on the apoptosis of epithelial cells induced by TNF-α in inflammatory bowel disease.
    Tang R; Yang G; Zhang S; Wu C; Chen M
    Inflamm Bowel Dis; 2014 Nov; 20(11):1950-61. PubMed ID: 25208103
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Adacolumn selective leukocyte adsorption apheresis in patients with active ulcerative colitis: clinical efficacy, effects on plasma IL-8, and expression of Toll-like receptor 2 on granulocytes.
    Aoki H; Nakamura K; Yoshimatsu Y; Tsuda Y; Irie M; Fukuda K; Hosoe N; Takada N; Shirai K; Suzuki Y
    Dig Dis Sci; 2007 Jun; 52(6):1427-33. PubMed ID: 17394078
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Granulocyte and monocyte adsorption apheresis therapy modulates monocyte-derived dendritic cell function in patients with ulcerative colitis.
    Iwakami Y; Sakuraba A; Sato T; Takada Y; Izumiya M; Ichikawa H; Hibi T
    Ther Apher Dial; 2009 Apr; 13(2):138-46. PubMed ID: 19379153
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Safety and effectiveness of granulocyte and monocyte adsorptive apheresis in patients with inflammatory bowel disease in special situations: a multicentre cohort study.
    Motoya S; Tanaka H; Shibuya T; Osada T; Yamamoto T; Hongo H; Mizuno C; Saito D; Aoyama N; Kobayashi T; Ito H; Tanida S; Nojima M; Kokuma S; Hosoi E
    BMC Gastroenterol; 2019 Nov; 19(1):196. PubMed ID: 31752695
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cytokine mucosal expression in ulcerative colitis, the relationship between cytokine release and disease activity.
    Pearl DS; Shah K; Whittaker MA; Nitch-Smith H; Brown JF; Shute JK; Trebble TM
    J Crohns Colitis; 2013 Jul; 7(6):481-9. PubMed ID: 22974822
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effect of toll-like receptor 3 agonist poly I:C on intestinal mucosa and epithelial barrier function in mouse models of acute colitis.
    Zhao HW; Yue YH; Han H; Chen XL; Lu YG; Zheng JM; Hou HT; Lang XM; He LL; Hu QL; Dun ZQ
    World J Gastroenterol; 2017 Feb; 23(6):999-1009. PubMed ID: 28246473
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dose-intensified granulocyte-monocyte apheresis in therapy refractory ulcerative colitis.
    Schultheiß C; Weischenberg R; Herrmann A; Haller B; Schmid RM; Reindl W; Huber W
    Artif Organs; 2015 Feb; 39(2):187-92. PubMed ID: 24981894
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Rectal Delivery of a DNAzyme That Specifically Blocks the Transcription Factor GATA3 and Reduces Colitis in Mice.
    Popp V; Gerlach K; Mott S; Turowska A; Garn H; Atreya R; Lehr HA; Ho IC; Renz H; Weigmann B; Neurath MF
    Gastroenterology; 2017 Jan; 152(1):176-192.e5. PubMed ID: 27639807
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protective effect of Averrhoa bilimbi L. fruit extract on ulcerative colitis in wistar rats via regulation of inflammatory mediators and cytokines.
    Suluvoy JK; Sakthivel KM; Guruvayoorappan C; Berlin Grace VM
    Biomed Pharmacother; 2017 Jul; 91():1113-1121. PubMed ID: 28531922
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Demonstration of low-regulatory CD25High+CD4+ and high-pro-inflammatory CD28-CD4+ T-Cell subsets in patients with ulcerative colitis: modified by selective granulocyte and monocyte adsorption apheresis.
    Yokoyama Y; Fukunaga K; Fukuda Y; Tozawa K; Kamikozuru K; Ohnishi K; Kusaka T; Kosaka T; Hida N; Ohda Y; Miwa H; Matsumoto T
    Dig Dis Sci; 2007 Oct; 52(10):2725-31. PubMed ID: 17404876
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Global mucosal and serum cytokine profile in patients with ulcerative colitis undergoing anti-TNF therapy.
    Dahlén R; Magnusson MK; Bajor A; Lasson A; Ung KA; Strid H; Öhman L
    Scand J Gastroenterol; 2015; 50(9):1118-26. PubMed ID: 25877762
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Pretreatment with alanyl-glutamine suppresses T-helper-cell-associated cytokine expression and reduces inflammatory responses in mice with acute DSS-induced colitis.
    Chu CC; Hou YC; Pai MH; Chao CJ; Yeh SL
    J Nutr Biochem; 2012 Sep; 23(9):1092-9. PubMed ID: 22137260
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M; Frin-Mathy G; Bzioueche H; Dainese R; Bernard G; Anty R; Filippi J; Saint-Paul MC; Tulic MK; Verhasselt V; Hébuterne X; Piche T
    Gut; 2014 May; 63(5):744-52. PubMed ID: 23878165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.